Handbook of Experimental Pharmacology Volume 1041
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
The Discovery of the Opioid Peptides John Hughes
THE DISCOVERY OF THE OPIOID PEPTIDES JOHN HUGHES Some time back I was interviewing Hannah Steinberg, and she said to me that she felt that one of the key discoveries was the discovery of enkephalin in the brain. This was brought to her in an unusual way when she went to try and get a copy of Nature to photocopy a copy of your article and found that the actual pages for that article had worn away - and this was only about 2 or 3 years after it had come out. Clearly it was a piece of work that caught the imagination not just for people within the field but of the wider public. Can I ask you how it all came about? Well like many of these things, scientific advances come about because, I guess, the individual scientists get fascinated by a particular problem. Why they get fascinated with that problem is often quite unclear. Okay some of the truly great may be want to understand the origin of life and so you have Watson and Crick and they went straight for it. The rest of us lesser mortals settle for what interests us, perhaps because of baggage we carry from the university, a particular lecture or a supervisor that really turned us on to a particular subject or particular area. Its difficult to say. I wanted to work in neuroscience. I knew that when then I completed my first degree but I also wanted to do medicine. I tried to combine both. I was at King's College Medical School for a while. -
Pharmacology International No. 83 December 2014 the Semi-Annual Newsletter from the International Union of Basic and Clinical Pharmacology
Pharmacology International No. 83 December 2014 The semi-annual newsletter from the International Union of Basic and Clinical Pharmacology In This Issue WCP2014 PharfA Pg. 9 Student Volunteer Pg. 13 Thank You Young Investigator Pg. 14 Competition Winners July 13 - 18, 2014 IOSP Satellite Meeting Pg. 16 IUPHAR Reports IOSP and ETRIS Pg. 19 Pharmacologists Enjoy Successful Teaching Resources th Education Section Pg. 21 17 World Congress of Basic and Clinical Pharmacology (WCP2014) Drug Metabolism and Pg. 25 in Cape Town, South Africa Drug Transporter Section Gastrointestinal Section Pg. 26 More than eight years have passed since the South African Society for Basic and Clinical Immunopharmacology Pg. 30 (ImmuPhar) Section Pharmacology won the bid in Beijing, China in 2006 to host this historic event in Cape Town. Geriatric Clinical Pg. 31 Including the satellite meetings in South Africa, the World Congress of Basic and Clinical Pharmacology Subcommittee Pharmacology (WCP2014) offered nearly three weeks of scientific activities in all areas of Pharmacoepidemiology & Pg. 32 basic and clinical aspects of medicines. It has been an amazing and successful journey. Pharmacovigilance Subcommittee Pediatric Clinical Pg. 33 Pharmacology Section The Congress Pharmacology from Cape Pg. 35 We were treated to a feast of more than 300 invited Town to Kyoto eminent scientists lecturing in more than 100 podium Latest News sessions in seven parallel tracks accompanied by Pr. Harmar Awarded J.R. Pg. 37 • Nobel Laureate Robert Lefkowitz (USA) as the Vane Medal Posthumously keynote opening address on G Protein Coupled GuideToPharmacology.org Pg. 38 Receptors (bottom left), New Release • Arthur Christopoulos (Australia) as the International Meet the 2014 - 2018 Pg. -
Leslie L. Iversen
Leslie L. Iversen BORN: Exeter, England October 31, 1937 EDUCATION: Cambridge University, B.A. (Biochemistry) (1961) Cambridge University, Ph.D. (Pharmacology) (1964) APPOINTMENTS: Postdoctoral Fellow, National Institutes of Health (1964–1965) Postdoctoral Fellow, Harvard Medical School (1965–1966) Research Fellow, Trinity College, Cambridge (1966–1967) Locke Research Fellow, Cambridge University (1967–1970) Director MRC Neurochemical Pharmacology Unit, Cambridge, (1970–1983) Director Neuroscience Research Centre, Merck Sharp & Dohme Ltd, Harlow, UK (1983–1995) Vice-President Neuroscience, Merck Research Labs (1986–1995) Visiting Professor of Pharmacology, Oxford University (1995–) Director, Wolfson Centre for Age Related Diseases, King’s College, London (1999–2004) HONORS AND AWARDS: Gaddum Lecturer, British Pharmacological Society (1971) F. O. Schmitt Lectureship, MIT, USA (1974) Associate of Neuroscience Research Program, MIT, USA (1975–1984) Fellow of the Royal Society, London (1980–) Honorary Member, American Academy of Arts and Sciences (1981–) Rennebohm Lecturer, University of Wisconsin, USA (1984) Ferrier Lecturer, Royal Society, London (1984) Foreign Associate Member, National Academy of Sciences USA (1986) Honoured Professor, Beijing Medical University, China (1988) Hans Kosterlitz Memorial Lecturer, British Physiological Soc (2000) Wellcome Gold Medal in Pharmacology, Brit. Pharm. Soc (2003) Lifetime Achievement Award, Brit. Assoc. Psychopharmacology (2006) Leslie Iversen has been at the forefront of research on neurotransmitters and neuropeptides and understanding the mode of action of CNS drugs. In his early work on catecholamines he was among the fi rst to describe the detailed properties and pharmacological specifi city of the noradrenaline transporter (NAT) in sympathetic nerves and brain, and he helped to strengthen the concept of antipsychotic drugs as dopamine receptor antagonists. -
AN ORAL HISTORY of NEUROPSYCHOPHARMACOLOGY the FIRST FIFTY YEARS Peer Interviews
AN ORAL HISTORY OF NEUROPSYCHOPHARMACOLOGY THE FIRST FIFTY YEARS Peer Interviews Volume Three: Neuropharmacology Copyright © 2011 ACNP Thomas A. Ban (series editor) AN ORAL HISTORY OF NEUROPSYCHOPHARMACOLOGY Fridolin Sulser (volume editor) VOLUME 3: NEUROPHARMACOLOGY All rights reserved. No part of this book may be used or reproduced in any manner without written permission from the American College of Neuropsychopharmacology (ACNP). Library of Congress Cataloging-in-Publication Data Thomas A. Ban, Fridoln Sulser (eds): An Oral History of Neuropsychopharmacology: The First Fifty Years, Peer Interviews Includes bibliographical references and index ISBN: 1461161614 ISBN-13: 9781461161615 1. Neuropharmacology 2. Neurotransmitterr era 3. Mode of action of psychotropic drugs 4. Psychotropic drug development Publisher: ACNP ACNP Executive Office 5034A Thoroughbred Lane Brentwood, Tennessee 37027 U.S.A. Email: [email protected] Website: www.acnp.org Cover design by Jessie Blackwell; JBlackwell Design www.jblackwelldesign.com AMERICAN COLLEGE OF NEUROPSYCHOPHARMACOLOGY AN ORAL HISTORY OF NEUROPSYCHOPHARMACOLOGY THE FIRST FIFTY YEARS Peer Interviews Edited by Thomas A. Ban Co-editors Volume 1: Starting Up - Edward Shorter Volume 2: Neurophysiology - Max Fink Volume 3: Neuropharmacology - Fridolin Sulser Volume 4: Psychoharmacology - Jerome Levine Volume 5: Neuropsychopharmacology - Samuel Gershon Volume 6: Addiction - Herbert D. Kleber Volume 7: Special Areas - Barry Blackwell Volume 8: Diverse Topics - Carl Salzman Volume 9: Update - Barry Blackwell Volume 10: History of the ACNP - Martin M. Katz VOLUME 3 NEUROPHARMACOLOGY ACNP 2011 VOLUME 3 Fridolin Sulser NEUROPHARMACOLOGY The Neurotransmitter Era in Neuropsychopharmacology Preface Thomas A. Ban Dedicated to the Memory of Bernard B. Brodie, President ACNP, 1965 PREFACE Thomas A. Ban In 1957 Ralph Gerard coined the term “psychotropic drugs” for chemicals which can control or induce mental pathology.1 Neuropharmacology studies the molecular substrate involved in the mode of action of these drugs.